SMTL ID : 9nct.2 (1 other biounit)

Crystal Structure of WDR5 in complex with Triazole-Based Inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.11 Å

Oligo State

monomer

Ligands

1 x 01: 4-({6-cyclopropyl-8-[(2-methyl-1H-imidazol-1-yl)methyl]-4,5-dihydro-3H-naphtho[1,2-d][1,2,3]triazol-3-yl}methyl)-2-methoxybenzonitrile

01.1: 15 residues within 4Å: Chain A: A.137, V.138, S.139, S.181, F.223, F.239, P.263, Y.281, K.349, Y.350, C.351, I.352, F.353, I.395, L.411 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:A.137, A:F.223, A:F.239, A:F.239, A:Y.281, A:F.353, A:I.395, A:L.411 Hydrogen bonds: A:C.351 pi-Stacking: A:F.223, A:Y.350

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Coker, J.A. et al., Development and Characterization of Triazole-Based WDR5 Inhibitors for the Treatment of Glioblastoma. Biorxiv (2025)

Release Date

2025-08-13

Peptides

WD repeat-containing protein 5: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

WD repeat-containing protein 5

Related Entries With Identical Sequence